Paper28711
"Akinetic depression" in schizophrenia.
Van Putten T and 1 other. Arch Gen Psychiatry, 1978. Cited by 294 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. "Akinetic depression" in schizophrenia. Papers, record 28711. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/28711
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Journal Article, Research Support, U.S. Gov't, Non-P.H.S., Research Support, U.S. Gov't, P.H.S.
- PubMed
Topics5
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antipsychotic Agents | Major topic |
| Depression | Major topic |
| Schizophrenia | Major topic |
| Humans | |
| Sleep Stages |
Source PubMed
Cited by44
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 294 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 39,006,901 | Diagnosis and treatment depression in schizophrenia. | Consort Psychiatr | 2020 | https://conductscience.org/library/papers/39006901 | PubMed |
| 37,083,542 | Antidepressive Effectiveness of Amisulpride, Aripiprazole, and Olanzapine in Patients With Schizophrenia Spectrum Disorders: A Secondary Outcome Analysis of a Pragmatic, Randomized Trial (BeSt InTro). | J Clin Psychopharmacol | 2023 | https://conductscience.org/library/papers/37083542 | PubMed |
| 36,624,935 | Longitudinal effect of clozapine-associated sedation on motivation in schizophrenia: naturalistic longitudinal study. | Br J Psychiatry | 2023 | https://conductscience.org/library/papers/36624935 | PubMed |
| 33,151,310 | Antidepressive Effect of Antipsychotics in the Treatment of Schizophrenia: Meta-Regression Analysis of Randomized Placebo-Controlled Trials. | Int J Neuropsychopharmacol | 2021 | https://conductscience.org/library/papers/33151310 | PubMed |
| 30,511,350 | Revisiting the Concept of Subjective Tolerability to Antipsychotic Medications in Schizophrenia and its Clinical and Research Implications: 30 Years Later. | CNS Drugs | 2019 | https://conductscience.org/library/papers/30511350 | PubMed |
| 29,942,132 | Structural equation modeling approach between salience network dysfunction, depressed mood, and subjective quality of life in schizophrenia: an ICA resting-state fMRI study. | Neuropsychiatr Dis Treat | 2018 | https://conductscience.org/library/papers/29942132 | PubMed |
| 22,028,735 | Suicidal behavior in the older patient with schizophrenia. | Aging health | 2011 | https://conductscience.org/library/papers/22028735 | PubMed |
| 21,254,789 | Managing suicide risk in patients with schizophrenia. | CNS Drugs | 2011 | https://conductscience.org/library/papers/21254789 | PubMed |
| 19,011,234 | Psychiatric comorbidities and schizophrenia. | Schizophr Bull | 2009 | https://conductscience.org/library/papers/19011234 | PubMed |
| 18,665,657 | Co-occurring depressive symptoms in the older patient with schizophrenia. | Drugs Aging | 2008 | https://conductscience.org/library/papers/18665657 | PubMed |
| 18,180,760 | How effective are second-generation antipsychotic drugs? A meta-analysis of placebo-controlled trials. | Mol Psychiatry | 2009 | https://conductscience.org/library/papers/18180760 | PubMed |
| 17,960,353 | [New insights into the pathogenesis and pathophysiology of depression]. | Nervenarzt | 2007 | https://conductscience.org/library/papers/17960353 | PubMed |
| 17,284,095 | Lack of insight in schizophrenia: impact on treatment adherence. | CNS Drugs | 2007 | https://conductscience.org/library/papers/17284095 | PubMed |
| 17,139,353 | The relationships between depression and remission in first-episode psychosis. | World Psychiatry | 2006 | https://conductscience.org/library/papers/17139353 | PubMed |
| 16,760,421 | Does self-perceived mood predict more variance in cognitive performance than clinician-rated symptoms in schizophrenia? | Schizophr Bull | 2006 | https://conductscience.org/library/papers/16760421 | PubMed |
| 16,640,124 | The impact of subjective well-being under neuroleptic treatment on compliance and remission. | Dialogues Clin Neurosci | 2006 | https://conductscience.org/library/papers/16640124 | PubMed |
| 16,492,798 | Subdomains within the negative symptoms of schizophrenia: commentary. | Schizophr Bull | 2006 | https://conductscience.org/library/papers/16492798 | PubMed |
| 15,995,904 | Psychological pathways to depression in schizophrenia: studies in acute psychosis, post psychotic depression and auditory hallucinations. | Eur Arch Psychiatry Clin Neurosci | 2005 | https://conductscience.org/library/papers/15995904 | PubMed |
| 15,995,903 | Antipsychotic and antidepressive effects of second generation antipsychotics: two different pharmacological mechanisms? | Eur Arch Psychiatry Clin Neurosci | 2005 | https://conductscience.org/library/papers/15995903 | PubMed |
| 15,812,601 | Antidepressive effects of traditional and second generation antipsychotics: a review of the clinical data. | Eur Arch Psychiatry Clin Neurosci | 2005 | https://conductscience.org/library/papers/15812601 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/28711
GET https://conductscience.org/api/papers/v1/28711/cited_by?page=2